Filter Results :

Your search for Biosimilars returned 37 reports

Sort by


Global Biologics and Biosimilars Market Research Report 2017

07 Sep 2017  |  Published by:  QYResearch
In this report, the global Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report is segmented into several key Regions, with production, consumption, ...

$ 2,900.00

Read More

2017-2022 Global and Regional Biologics and Biosimilars Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

30 Aug 2017  |  Published by:  HNY Research
This report focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions such as Europe, North America, China, Japan, Southeast Asia and e...

$ 3,500.00

Read More

Japan Biosimilars - A start of Authorized Biosimilar Era? Biosimilar/BioPharma CMO opportunities - JP Conglomerates – A definite role to play for Global Market! Major JP Innovator vs. Early entrant Mid size Japanese companies- TA focus approach - A Win Win Game!

14 Aug 2017  |  Published by:  MP Advisors
In 2016, encouraging uptake of Lantus BS in Japan confirms strong foothold of the marketer, product mix targeted to DPC hospitals (Diagnostic Procedure Combination hospitals- ~4000) and early entry of the player are critical factors to decide biosimilar penetration and market share dynamics of Japan...

$ 4,000.00

Read More

2017 Global and Regional Biologics and Biosimilars Market Research Report Forecasts 2022

26 Jul 2017  |  Published by:  Tuoda Research
This report focus on Global and regional market providing information on major players like manufacturers suppliers distributors traders customers investors and etc. major types major applications from Global and major regions such as Europe North American South American Asia (Excluding China) China...

$ 2,800.00

Read More

2017 Global and Regional Biosimilars and Biologics Market Research Report Forecasts 2022

08 Jul 2017  |  Published by:  Tuoda Research
This report focus on Global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from Global and major regions such as Europe, North American, South American, Asia (Excluding C...

$ 2,800.00

Read More

Global Biosimilars Market Analysis 2011-2017 and Forecast 2018-2023

01 Jul 2017  |  Published by:  99Strategy
SnapshotA biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.The global Biosimilars market will reach Volume Million USD in 2017 and CAGR xx% 201...

$ 2,980.00

Read More

Global Oncology Biosimilars Market Research Report Forecast 2017 to 2021

07 Jun 2017  |  Published by:  S&P Consulting
The Global Oncology Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). T...

$ 2,800.00

Read More

Global Biologics and Biosimilars Market Analysis 2011-2017 and Forecast 2018-2023

01 Jun 2017  |  Published by:  99Strategy
SnapshotA biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or ...

$ 2,980.00

Read More

The Future of Biosimilars in Europe

01 Jun 2017  |  Published by:  FirstWord
Education is top priority as biosimilar mAbs enter the marketWith the recent approval of Celltrion’s Truxima, all eyes are on biosimilar oncology monoclonal antibodies (mAbs). Experts say they’re the next frontier in the European biosimilars market, but warn that they may not achieve widespread upta...

$ 2,245.00

Read More

EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017

10 May 2017  |  Published by:  QYResearch
In this report, the EMEA Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), ...

$ 4,000.00

Read More

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

01 Apr 2017  |  Published by:  GBI Research
SummaryRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years. Disease progression results in stiffness and pain, especially in the hands a...

$ 4,995.00

Read More

Biosimilars: US Payer Perspectives (2017)

01 Apr 2017  |  Published by:  FirstWord
Will biosimilar provide a ‘magic bullet’ to drug prices in the US? Payers speak out… Biosimilars continue to be big business in the US, but has progress has been too slow? Not so, argue payers. While the number of biosimilar approvals in the US still lags behind Europe, a solid foundation continues ...

$ 2,245.00

Read More

Biosimilars in Emerging Markets (2017)

01 Mar 2017  |  Published by:  FirstWord
Biosimilars: Make the most of high risk emerging market opportunities Emerging biosimilars markets are currently a $5billion opportunity with even more growth potential ahead. Lower drug costs and improved patient access are attractive to governments, insurers and patients too. But with market regul...

$ 2,245.00

Read More

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets

01 Mar 2017  |  Published by:  GBI Research
SummaryThe cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covere...

$ 4,995.00

Read More

Biosimilars: European Payer Perspectives

01 Feb 2017  |  Published by:  FirstWord
What is the future for biosimilars in the EU?What issues do EU Payers think will impact adoption, pricing and reimbursement of biosimilars?In January 2016 Samsung Bioepis launched Benepali, a biosimilar version of Enbrel marking a significant advance in biosimilar therapy options.  With biosimi...

$ 2,245.00

Read More
Total 37 records.